Different medical conditions, aging, and lifestyle habits can all contribute to these symptoms. When nondrug strategies fail to help, medications are available to address symptoms and improve quality ...
Various medications that treat narcolepsy are available, and treatment plans can vary based on individual symptoms and other factors. Healthcare providers often start with one medication but may need ...
Valued at a market cap of $13.3 billion, Incyte Corporation (INCY) is a biopharmaceutical company that engages in the ...
Drug treatments are also used to treat the disease, but the standard first-line therapies of hydroxyurea or interferons are not particularly effective at controlling blood counts and can be poorly ...
The best diabetes medication for kidney disease can vary depending on the severity of your kidney damage. You may need a medication that doesn’t require dose adjustment based on your kidney ...
The FDA approves Mesoblast's Ryoncil (remestemcel-L) for treating pediatric patients with steroid-refractory acute graft ...
Historically, sickle cell anaemia has been widely neglected within its global epicentre of sub-Saharan Africa. More than ...
Too much of anything can be bad, and the consequence of too much of drugs is something we are all familiar with. Not all of us have tried these drugs, but cinema has shown us the most graphic and ...
The molecular basis and mechanisms of action of combining classic cytotoxic agents (e.g. platinum-containing drugs, taxanes, etc.) and novel agents (e.g. tirapazamine, EGFR inhibitors and other ...
Myeloproliferative diseases are a heterogeneous group of conditions characterized by excessive cellular proliferation of one or more types of peripheral blood cells.
The radiosensitizing ability of a drug can be expressed by the therapeutic ratio. This ratio is derived from sigmoid-shaped dose−response curves, calculated by plotting the response of tissues ...
Squibb, on the other hand, delved into cancer research, discovering and developing hydroxyurea for leukemia ... The company also joined the UNAIDS Drug ACCESS Initiative, along with four other ...